For further advance psoriasis slow disease management, the standard diagnosis and treatment of patients with psoriasis by psoriasis skin venereology branch of Chinese medical association professional committee and health services in anhui province association hosted the 2020 psoriasis therapy refers to southern China speak, dandelion action and GPA online training session for the seventh session on November 6, 2020, in "optimal wheat doctor" online platform meeting successfully.

        The meeting was chaired by Professor Mu Qili, director of Dermatology of Inner Mongolia International Mongolian Medical Hospital, and Professor Shi Jihai, Secretary of the First Affiliated Hospital of Baotou Medical College. Skin disease hospital affiliated to Shanghai tongji university, dean and tongji university professor, director of the institute of medicine psoriasis yu-ling shi, professor of Peking University third hospital dermatological department director zhang cl, the people's liberation army general hospital cheng-xin li, director of the professor of dermatology, the first medical center, first affiliated hospital of Inner Mongolia medical university dermatologist jian-wen han professor, deputy director of the psoriasis skin venereology branch of Chinese medical association professional committee of the secretary, national dermatologist Dr Zheng-wei zhu and psoriatic patients a total of more than 900 people attended the online meeting.

        The first half of the meeting was presided over by Professor Shi Jihai. First by yu-ling shi, professor of biological treatment of patients with psoriasis expert consensus of the People's Republic of China, has carried on the induction summary to the biological agents for the treatment of psoriasis, from targets to the comparison of structure and function, and biological agents screening and side effect of the treatment of psoriasis treatment, let it be for the treatment of biological agents have a more profound understanding, to guide the clinical reasonable use of biological agents safely.

        Professor Li chengxin's lecture title was psoriasis: From Skin to System. He explained in detail the role of Th17/IL-23 axis in psoriasis and cardiovascular and metabolic diseases, so as to enable people to have a fuller and comprehensive understanding of psoriasis. Instead of focusing only on the skin problems of patients, it is more important to monitor the systemic problems of patients.

        Professor Zhang Chunlei emphasized the advantages and disadvantages of Chinese external drugs in the 2018 Edition of Interpretation of Chinese Guidelines for The Diagnosis and Treatment of Psoriasis, as well as the selection principles of various types of external drugs for psoriasis and the methods of sequential treatment. It is expected that dermatologists in China will further standardize the treatment of psoriasis under the guidance of the guidelines.

        The second half of the meeting was presided over by Professor Kiki. In the session of "Dandelion Action -- Popular Science Education for Patients", Professor Han Jianwen explained the treatment plan more suitable for Chinese patients with psoriasis. The treasuryucumab can inhibit IL-17A, which is more in line with the target of Chinese population, has safe curative effect, and can prevent comorbid psoriasis, thus providing an effective and reliable plan for the treatment of psoriasis.

        Dr. Zhu Zhengwei introduced the 2020 China Psoriasis Monitoring Program (CGPA). The objective of CGPA is to understand the distribution, disease status, disease burden, economic burden and quality of life of psoriasis patients in China. Establish a psoriasis research cohort with long-term follow-up of patients to improve the status of health care for psoriasis, reduce the burden on patients, and improve the quality of life of patients, so as to provide information for research, policy and health care of the disease in China. At this stage, based on CGPA and psoriasis clinics, psoriasis patients are recruited across the country to participate in the psoriasis questionnaire survey, complete the epidemiological survey of CGPA psoriasis patients, assist the new Version of China's psoriasis diagnosis and treatment guidelines and expert consensus tour of biological agents, and conduct psoriasis education - Dandelion Action.

        During the discussion session, the professors discussed the problems in the treatment of psoriasis with biologics, Shared their experience in using biologics, and answered the questions raised by the online doctors.

        At last, Professor Muqiri made a summary of this meeting. This tour not only answers dermatologists' questions, but also improves the diagnosis and treatment level, and enables patients to have a deeper understanding of their own diseases. It is expected that with the joint efforts of the psoriasis Professional Committee, psoriasis outpatient department, psoriasis Research Center and CGPA member unit, the conference will provide Chinese data for the global epidemiological resources of psoriasis, improve the diagnosis and treatment level of Chinese dermatologists, and benefit every psoriasis patient.